Cambridge puts a lid on biolabs

After watching the controversy surrounding a high-security biolab in Boston, officials in Cambridge are preparing new rules that would bar development of such labs in their town. Report

Suggested Articles

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.

Efforts to pivot existing discoveries into COVID-19 cures may not bear fruit until the pandemic has ended but could help fend off future outbreaks.